Search

Search Constraints

You searched for: Date 2020 Author/Creator He, Li-Zhen

Search Results

1. 406 CDX527–01, a phase 1 dose-escalation and expansion study of the PD-L1xCD27 bispecific antibody CDX-527 in patients with advanced malignancies. (9th November 2020)

2. 406 CDX527–01, a phase 1 dose-escalation and expansion study of the PD-L1xCD27 bispecific antibody CDX-527 in patients with advanced malignancies. (9th November 2020)

3. 550 An Axl-targeting monoclonal antibody that inhibits Axl activity and potently stimulates the innate immune response. (9th November 2020)

4. 550 An Axl-targeting monoclonal antibody that inhibits Axl activity and potently stimulates the innate immune response. (9th November 2020)